Depressed contractile reserve and impaired calcium handling of cardiac myocytes from chronically unloaded hearts are ameliorated with the administration of physiological treatment dose of T3 in rats

Acta Physiologica

Volumn 189, Issue 3, 2007, Pages 221-231

  Minatoya, Y ^a   Ito, K ^a   Kagaya, Y ^a   Asaumi, Y ^a   Takeda, M ^a   Nakayama, M ^a   Takahashi, J ^a   Iguchi, A ^a   Shirato, K ^a   Shimokawa, H ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium handling; Cardiac myocytes; Phospholamban; Thyroid hormone; Transplantation

Indexed keywords

LIOTHYRONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; HEART CONTRACTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART STRESS; HEART TRANSPLANTATION; HYPERTHYROIDISM; MALE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SYSTOLE;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; HEART TRANSPLANTATION; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; TRANSPLANTATION, ISOGENEIC; TRIIODOTHYRONINE;

EID: 33846999623     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2006.01636.x     Document Type: Article

References (64)

1. Antoons, G., Vangheluwe, P., Volders, P.G. et al. 2006. Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure. J Mol Cell Cardiol 40, 350-360.
2. Barton, P.J., Felkin, L.E., Birks, E.J. et al. 2005. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation 112, I46-I50.
3. Bers, D.M. 2002. Cardiac excitation-contraction coupling. Nature 415, 198-205.
4. Birks, E.J., Yacoub, M.H., Banner, N.R. et al. 2004. The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol 19, 148-153.
5. Blough, E.R., Rennie, E.R., Zhang, F. et al. 1996. Enhanced electrophoretic separation and resolution of myosin heavy chains in mammalian and avian skeletal muscles. Anal Biochem 233, 31-35.
6. Brittsan, A.G. & Kranias, E.G. 2000. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 32, 2131-2139.
7. 2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem 275, 12129-12135.
8. Brixius, K., Wollmer, A., Bolck, B. et al. 2003. Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflugers Arch 447, 150-157.
9. Bungo, M.W., Goldwater, D.J., Popp, R.L. et al. 1987. Echocardiographic evaluation of space shuttle crewmembers. J Appl Physiol 62, 278-283.
10. Burkhoff, D., Klotz, S. & Mancini, D.M. 2006. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail 12, 227-239.
11. Cao, X., Kambe, F., Moeller, L.C., Refetoff, S. & Seo, H. 2005. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19, 102-112.
12. 2+-ATPase and alpha-myosin heavy chain in rat hearts. J Clin Invest 100, 1742-1749.
13. Danzi, S., Dubon, P. & Klein, I. 2005. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. Am J Physiol 289, H1506-H1511.
14. Degens, H., Gilde, A.J., Lindhout, M. et al. 2003. Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. Am J Physiol 284, H108-H115.
15. Deng, M.C., Edwards, L.B., Hertz, M.I. et al. 2005. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report - 2005. J Heart Lung Transplant 24, 1182-1187.
16. Depre, C., Shipley, G.L., Chen, W. et al. 1998. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4, 1269-1275.
17. Dillmann, W.H. 1990. Biochemical basis of thyroid hormone action in the heart. Am J Med 88, 626-630.
18. Faber, M.J., Agnetti, G., Bezstarosti, K. et al. 2006. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure. Cell Biochem Biophys 44, 11-29.
19. Farrar, D.J., Holman, W.R., McBride, L.R. et al. 2002. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 21, 516-521.
20. Furuya, F., Hanover, J.A. & Cheng, S.Y. 2006. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor. Proc Natl Acad Sci USA 103, 1780-1785.
21. Grimm, D., Bauer, J., Kossmehl, P. et al. 2002. Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. Faseb J 16, 604-606.
22. Hasenfuss, G. 1998. Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39, 60-76.
23. Helman, D.N., Maybaum, S.W., Morales, D.L. et al. 2000. Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable? Ann Thorac Surg 70, 1255-1258.
24. Hetzer, R., Muller, J.H., Weng, Y. et al. 2001. Bridging-to-recovery. Ann Thorac Surg 71, S109-S113; discussion S114-S115.
25. Hunter, J.J. & Chien, K.R. 1999. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999 341, 1276-1283.
26. Ito, K., Kagaya, Y., Ishizuka, T., Ito, N., Ishide, N. & Shirato, K. 1999. Diacylglycerol delays pH(i) overshoot after reperfusion and attenuates contracture in isolated, paced myocytes. Am J Physiol 277, H1708-H1717.
27. Ito, K., Yan, X., Tajima, M., Su, Z., Barry, W.H. & Lorell, B.H. 2000. Contractile reserve and intracellular calcium regulation in mouse myocytes from normal and hypertrophied failing hearts. Circ Res 87, 588-595.
28. Ito, K., Nakayama, M., Hasan, F., Yan, X., Schneider, M.D.& Lorell, B.H. 2003. Contractile reserve and calcium regulation are depressed in myocytes from chronically unloaded hearts. Circulation 107, 1176-1182.
29. Kinugawa, K., Yonekura, K., Ribeiro, R.C. et al. 2001. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89, 591-598.
30. 2+ transport and myocardial relaxation. Circ Res 75, 245-251.
31. Kitamura, M., Shimizu, M., Kita, Y. et al. 1997. Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer. Jpn Circ J 61, 781-786.
32. Klein, I. & Hong, C. 1986. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77, 1694-1698.
33. Klein, I. & Ojamaa, K. 2001. Thyroid hormone and the cardiovascular system. N Engl J Med 344, 501-509.
34. Klein, I., Hong, C. & Schreiber, S.S. 1991. Isovolumic loading prevents atrophy of the heterotopically transplanted rat heart. Circ Res 69, 1421-1425.
35. Korecky, B. & Masika, M. 1991. Direct effect of increased hemodynamic load on cardiac mass. Circ Res 68, 1174-1178.
36. 2+ transport in atrophic heart transplants in rat. Am J Physiol 251, H941-H948.
37. Kumpati, G.S., McCarthy, P.M. & Hoercher, K.J. 2001. Left ventricular assist device bridge to recovery: a review of the current status. Ann Thorac Surg 271, S103-S108; discussion S114-S105.
38. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
39. MacLennan, D.H. & Kranias, E.G. 2003. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4, 566-577.
40. Mancini, D. & Burkhoff, D. 2005. Mechanical device-based methods of managing and treating heart failure. Circulation 112, 438-448.
41. Margulies, K.B. 2002. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 8, S500-S505.
42. 2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. Faseb J 17, 61-63.
43. Ojamaa, K., Samarel, A.M., Kupfer, J.M. et al. 1992. Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. Am J Physiol 263, E534-E540.
44. Ojamaa, K., Kenessey, A., Shenoy, R. et al. 2000a. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol 279, E1319-E1324.
45. Ojamaa, K., Kenessey, A. & Klein, I. 2000b. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141, 2139-2144.
46. Ono, K. & Lindsey, E.S. 1969. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57, 225-229.
47. Pantos, C.I., Malliopoulou, V.A., Mourouzis, I.S. et al. 2002. Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 12, 325-329.
48. Pantos, C., Malliopoulou, V., Mourouzis, I. et al. 2003. Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol 478, 53-60.
49. Pantos, C., Malliopoulou, V., Varonos, D.D. & Cokkinos, D.V. 2004. Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol 99, 101-120.
50. Pantos, C., Mourouzis, I., Saranteas, T. et al. 2005. Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Basic Res Cardiol 100, 422-432.
51. Pantos, C., Malliopoulou, V., Mourouzis, I. et al. 2006. Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Horm Metab Res 38, 308-313.
52. Philpott, D.E., Popova, I.A., Kato, K. et al. 1990. Morphological and biochemical examination of Cosmos 1887 rat heart tissue: Part I - Ultrastructure. Faseb J 4, 73-78.
53. Rakusan, K., Heron, M.I., Kolar, F. et al. 1997. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. J Mol Cell Cardiol 29, 1045-1054.
54. Razeghi, P., Myers, T.J., Frazier, O.H. & Taegtmeyer, H. 2002. Reverse remodeling of the failing human heart with mechanical unloading. Emerging concepts and unanswered questions. Cardiology 98, 167-174.
55. Reiser, P.J. & Kline, W.O. 1998. Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am J Physiol 274, H1048-H1053.
56. Sabbah, H.N., Sharov, V.G., Gupta, R.C. et al. 2003. Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res 93, 1095-1101.
57. Strollo, F. 1999. Hormonal changes in humans during space-flight. Adv Space Biol Med 7, 99-129.
58. Tajima, M., Weinberg, E.O., Bartunek, J. et al. 1999. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation 99, 127-134.
59. Talmadge, R.J. & Roy, R.R. 1993. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75, 2337-2340.
60. Tsuneyoshi, H., Oriyanhan, W., Kanemitsu, H. et al. 2005. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Circulation 112, I51-I56.
61. Welsh, D.C., Dipla, K., McNulty, P.H. et al. 2001. Preserved contractile function despite atrophic remodeling in unloaded rat hearts. Am J Physiol 281, H1131-H1136.
62. Wohlschlaeger, J., Schmitz, K.J., Schmid, C. et al. 2005. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 68, 376-386.
63. Yacoub, M.H. 2001. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22, 534-540.
64. Zinman, T., Shneyvays, V., Tribulova, N. et al. 2006. Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J Cell Physiol 207, 220-231.